ProQR Therapeutics N.V. (NASDAQ: PRQR)
$2.4100
-0.2100 ( -6.95% ) 191.0K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.